 
                 
                 
            Drexel University’s online MS in Drug Discovery and Development offers you the specialized training and real-world insight you need to find success and enable advancement in the field of drug discovery and development. This unique program provides the rigorous scientific and technical training necessary to succeed in this complex and multidisciplinary field, and facilitates a smooth transition to an enduring and productive career with a biotechnology firm, pharmaceutical company, contract research or nonprofit organization, or an academic institution.
Drug discovery and development is the process by which new drugs are produced and brought to market. The FDA states that there are five stages in the drug development process: discovery, preclinical research, clinical research, FDA review, and FDA post-market safety monitoring.
Drexel’s online MS in Drug Discovery and Development teaches you to understand, evaluate, and engage with every stage in this discovery and development process. The core curriculum is supported by a large offering of specialized courses that allow you to focus on areas like:
Drexel’s drug discovery graduate program offers a flexible curriculum highlighted by a core set of required courses that introduce the essential scientific underpinnings of the field and numerous specialized topics including:
| 
 | 
 | 
This is complemented by an extensive list of advanced electives that let you customize the program and focus on one or more areas of particular interest.
 "There were several programs I considered, but I ultimately felt that the Drexel MS in Drug Discovery & Development would give me the right combination of basic science training as well as a critical overview of the biomedical science industry."
"There were several programs I considered, but I ultimately felt that the Drexel MS in Drug Discovery & Development would give me the right combination of basic science training as well as a critical overview of the biomedical science industry."
Jillian McGonigle, MS
Affiliation: Pfizer
Position: Project Planner, Inflammation & Immunology
Caitlyn Durgin, MS
Affiliation: Pinney Associates
Position: Associate
Learn more about our Drug Discovery and Development students.
During this upcoming virtual event, the program directors will introduce you to the drug discovery & development programs, discuss the curriculum, and answer any questions you may have. Register today!
There seems to be a million kinds of medicine in your local pharmacy. But what does it take to get a drug to market? Drexel professor Richard Mangano explains the drug discovery and development process, and why some drugs get funded – and some don’t.
You must have a bachelor’s degree from a regionally accredited institution in the United States or an equivalent international institution in order to pursue this degree. Your GPA should be 3.0 or higher, and relevant work experience is considered very valuable.
Students who pursue the MS in Drug Discovery and Development come from various professional and academic backgrounds. You’ll learn alongside classmates who work at pharmaceutical, biotech, and contract research companies, and have backgrounds in life sciences, chemistry, engineering, and pharmaceutics. Ideal applicants for this program include:
Careers in Drug Discovery & Development
With a degree in drug discovery and development, you’ll be prepared for careers throughout the industry. Graduates from this program have gone on to work at companies like Merck, GSK, Janssen, Amgen, and the FDA. Some common career paths for graduates include:
Drexel’s online MS in Drug Discovery & Development is a 38 credit program. Most online students complete the program on a part-time basis. Courses are offered during fall, spring, and summer semesters so you can complete your MS in Drug Discovery & Development in as little as two years. Most students take two and a half to three years to complete the program.
Salaries for drug discovery and development roles will vary largely based on employer and location. However, according to the Bureau of Labor Statistics, some common job titles and salaries are:
The biopharmaceutical industry is enjoying steady growth in the number of jobs and wages with the average wage approaching $100,000 per year.
Will the online MS in Drug Discovery and Development program help me to network with industry professionals?
At Drexel University, we are proud of the industry expertise that our faculty bring to the classroom. They will be able to help you navigate the industry landscape and provide valuable career advice. In addition, the connections you make with your fellow students will provide a lifetime of networking opportunities. Drexel’s Drug Discovery and Development students are affiliated with some of the largest pharmaceutical companies in the world.
Student Affilitations
| 
 | 
 | 
Are there any awards associated with the online MS in Drug Discovery and Development program?
At Drexel University, we believe in rewarding hard work and dedication. That's why the Drug Discovery and Development program grants an Outstanding Achievement Award each year to students who exhibit consistently excellent performance throughout the program and graduate with the highest grade point average.
Meet this year’s Drug Discovery and Development Outstanding Achievement Award Winners:
Learn more about our Drug Discovery and Development students.
Dr. Paul McGonigle
Professor and Director
pm455@drexel.edu
Dr. Joanne Mathiasen
Professor and Co-Director
jrm398@drexel.edu
Drexel University offers a variety of Graduate Minors that can be added to any master's degree program.
State restrictions may apply to some programs.
Both a thesis and a non-thesis option are available. The non-thesis option requires the preparation of a scholarly document on a topic related to the biopharmaceutical field. The thesis option requires a written thesis that is focused on an area of concentration within the pharmaceutical industry. The thesis may be based on research (laboratory or otherwise) conducted within a pharmaceutical rotation, which may be at Drexel or at a pharmaceutical or biotechnology company, nonprofit or contract research organization, or a government agency.
| Required Courses | ||
| IDPT 500S | Responsible Conduct of Research | 2.0-3.0 | 
| or CR 612S | Fundamentals of Compliance | |
| NEUR 500S | Statistics for Neuro/Pharm Research | 2.0-3.0 | 
| or IDPT 501S | Biostatistics I | |
| or CR 520S | Applications of Clinical Research Biostatistics | |
| PHRM 512S | Graduate Pharmacology | 3.0 | 
| PHRM 525S | Drug Discovery and Development I | 3.0 | 
| PHRM 526S | Drug Discovery and Development II | 3.0 | 
| PHRM 527S | Current Topics in Drug Discovery and Development | 1.0 | 
| PHRM 605S | Research in Drug Discovery and Development | 4.0 | 
| or PHRM 610S | or Practicum in Drug Discovery and Development | |
| Electives * | 18.0 | |
| Total Credits | 36.0-38.0 | |
With multiple ways to submit documents, Drexel makes it easy to complete your application. Learn more by visiting our Completing Your Application Guide.
For the academic year 2025-2026, students enrolled in an online graduate academic program will be charged a graduate online program fee of $125 per year.
One of the major strengths of the Drug Discovery and Development program is the diversity and extent of faculty with significant industry experience. This includes five full-time faculty members with over 100 combined years of experience as both scientists and senior executives in the pharmaceutical and biotech fields. The adjunct faculty consists of over 30 active professionals and includes several senior level executives from regional and national companies whose expertise includes topics ranging from target identification and validation to commercialization and marketing.
|  | Paul McGonigle, PhD  Dr. McGonigle has an extensive industry background with companies such as Wyeth Research, NeuroGenix, and Psychogenics. His research interests include CNS drug discovery, receptor pharmacology, behavioral pharmacology, and neuropharmacology | 
|  | Joanne Mathiasen, PhD  Dr. Mathiasen has a robust background with industry leaders such as Johnson & Johnson, Cephalon, and Teva. Her research interests include CNS drug discovery, behavioral pharmacology, neuropharmacology, and pain and cognition. | 
2025-2026 Academic Year
Term
Classes Begin
Classes End
Fall 2025
August 18, 2025
December 12, 2025
Spring 2026
January 5, 2026
May 1, 2026
Summer 2026
May 11, 2026
August 7, 2026
 
        